Trade ProQR Therapeutics NV - PRQR CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.05
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021485 %(-$1.07)Trade size with leverage ~ $5,000.00Money from leverage ~ $4,000.00Go to platform: -0.02149%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000738 %(-$0.04)Trade size with leverage ~ $5,000.00Money from leverage ~ $4,000.00Go to platform: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 20.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021485 %
  (-$1.07)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000738 %
  (-$0.04)

Key Stats

• Prev. Close: 1.82
• Open: 1.83
• 1-Year Change: -8.5%
• Day's Range: 1.81 - 1.92

Trade ProQR Therapeutics NV - PRQR

What is ProQR Therapeutics NV (PRQR)?

ProQR Therapeutics NV is a biotechnology company focused on the discovery and development of RNA-based therapies for genetic disorders. The company utilizes proprietary RNA technology platforms to design treatments that target the underlying causes of inherited diseases. Its pipeline includes candidates aimed at addressing conditions affecting the eyes, lungs, and other organs. ProQR's approach involves modifying RNA to restore or alter gene expression, offering potential therapeutic benefits. The company collaborates with academic institutions and industry partners to advance its research and development efforts. It operates within the biopharmaceutical sector, emphasizing innovation in genetic medicine.

ProQR Therapeutics NV Stock Price Today: Live Overview

The price today is shaped by active session trading, as Invesco S&P 500 Revenue ETF stands at $1.95. It has traded between $1.81 and $1.84 during the day, showing a daily change of -2.1622%.

FAQ: ProQR Therapeutics NV (PRQR)

What is the current price of PRQR stock?

ProQR Therapeutics NV's current price is $1.95.

Does PRQR pay dividends?

ProQR Therapeutics NV does not pay dividends.

Does PRQR have a formal corporate presence or regional headquarters in the UAE?

ProQR Therapeutics NV has a registered presence in the UAE through a regional office in Dubai Internet City.

What is PRQR best known for?

ProQR Therapeutics NV is most famous for developing RNA-based therapies for genetic disorders.

What assets are typically shown together with PRQR?

Commonly shown alongside PRQR: Dnb, Uber Technologies Inc, Pluri Inc.